Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats.

Zamberletti E, Gabaglio M, Woolley-Roberts M, Bingham S, Rubino T, Parolaro D.

Front Cell Neurosci. 2019 Aug 9;13:367. doi: 10.3389/fncel.2019.00367. eCollection 2019.

2.

Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice.

Zamberletti E, Gabaglio M, Piscitelli F, Brodie JS, Woolley-Roberts M, Barbiero I, Tramarin M, Binelli G, Landsberger N, Kilstrup-Nielsen C, Rubino T, Di Marzo V, Parolaro D.

J Psychopharmacol. 2019 Jul;33(7):894-907. doi: 10.1177/0269881119844184. Epub 2019 May 14.

PMID:
31084246
3.

Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling.

Cuccurazzu B, Zamberletti E, Nazzaro C, Prini P, Trusel M, Grilli M, Parolaro D, Tonini R, Rubino T.

Int J Neuropsychopharmacol. 2018 Nov 1;21(11):1014-1024. doi: 10.1093/ijnp/pyy057.

4.

Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex.

Prini P, Rusconi F, Zamberletti E, Gabaglio M, Penna F, Fasano M, Battaglioli E, Parolaro D, Rubino T.

J Psychiatry Neurosci. 2018 Mar;43(2):87-101.

5.

Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex.

Prini P, Rusconi F, Zamberletti E, Gabaglio M, Penna F, Fasano M, Battaglioli E, Parolaro D, Rubino T.

J Psychiatry Neurosci. 2017 Nov;42(6):170082. doi: 10.1503/jpn.170082. Epub 2017 Oct 12.

6.

The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models.

Zamberletti E, Gabaglio M, Parolaro D.

Int J Mol Sci. 2017 Sep 7;18(9). pii: E1916. doi: 10.3390/ijms18091916. Review.

7.

Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex.

Scheggia D, Zamberletti E, Realini N, Mereu M, Contarini G, Ferretti V, Managò F, Margiani G, Brunoro R, Rubino T, De Luca MA, Piomelli D, Parolaro D, Papaleo F.

Mol Psychiatry. 2018 Apr;23(4):1040-1050. doi: 10.1038/mp.2017.126. Epub 2017 Jun 20.

PMID:
28630452
8.

New vistas on cannabis use disorder.

Melis M, Frau R, Kalivas PW, Spencer S, Chioma V, Zamberletti E, Rubino T, Parolaro D.

Neuropharmacology. 2017 Sep 15;124:62-72. doi: 10.1016/j.neuropharm.2017.03.033. Epub 2017 Mar 31. Review.

9.

Lifelong imbalanced LA/ALA intake impairs emotional and cognitive behavior via changes in brain endocannabinoid system.

Zamberletti E, Piscitelli F, De Castro V, Murru E, Gabaglio M, Colucci P, Fanali C, Prini P, Bisogno T, Maccarrone M, Campolongo P, Banni S, Rubino T, Parolaro D.

J Lipid Res. 2017 Feb;58(2):301-316. doi: 10.1194/jlr.M068387. Epub 2016 Nov 30.

10.

The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function.

Struik D, Fadda P, Zara T, Zamberletti E, Rubino T, Parolaro D, Fratta W, Fattore L.

Pharmacol Res. 2017 Jan;115:209-217. doi: 10.1016/j.phrs.2016.11.031. Epub 2016 Nov 24.

PMID:
27890818
11.

Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats.

Zamberletti E, Gabaglio M, Grilli M, Prini P, Catanese A, Pittaluga A, Marchi M, Rubino T, Parolaro D.

Pharmacol Res. 2016 Sep;111:459-470. doi: 10.1016/j.phrs.2016.07.008. Epub 2016 Jul 12.

PMID:
27422357
12.

Assay of GTPγS Binding in Autoradiography.

Gabaglio M, Prini P, Zamberletti E, Rubino T, Parolaro D.

Methods Mol Biol. 2016;1412:95-101. doi: 10.1007/978-1-4939-3539-0_10.

PMID:
27245895
13.

MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background.

Cobolli Gigli C, Scaramuzza L, Gandaglia A, Bellini E, Gabaglio M, Parolaro D, Kilstrup-Nielsen C, Landsberger N, Bedogni F.

PLoS One. 2016 Apr 20;11(4):e0153473. doi: 10.1371/journal.pone.0153473. eCollection 2016.

14.

Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.

Zamberletti E, Gabaglio M, Prini P, Rubino T, Parolaro D.

Eur Neuropsychopharmacol. 2015 Dec;25(12):2404-15. doi: 10.1016/j.euroneuro.2015.09.021. Epub 2015 Oct 21.

PMID:
26499171
15.

Endocannabinoids and Mental Disorders.

Rubino T, Zamberletti E, Parolaro D.

Handb Exp Pharmacol. 2015;231:261-83. doi: 10.1007/978-3-319-20825-1_9. Review.

PMID:
26408164
16.

The Impact of Exposure to Cannabinoids in Adolescence: Insights From Animal Models.

Rubino T, Parolaro D.

Biol Psychiatry. 2016 Apr 1;79(7):578-85. doi: 10.1016/j.biopsych.2015.07.024. Epub 2015 Aug 7. Review.

PMID:
26344755
17.

Sex-dependent vulnerability to cannabis abuse in adolescence.

Rubino T, Parolaro D.

Front Psychiatry. 2015 Apr 20;6:56. doi: 10.3389/fpsyt.2015.00056. eCollection 2015. Review.

18.

The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects.

Cascio MG, Zamberletti E, Marini P, Parolaro D, Pertwee RG.

Br J Pharmacol. 2015 Mar;172(5):1305-18. doi: 10.1111/bph.13000.

19.

Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex.

Rubino T, Prini P, Piscitelli F, Zamberletti E, Trusel M, Melis M, Sagheddu C, Ligresti A, Tonini R, Di Marzo V, Parolaro D.

Neurobiol Dis. 2015 Jan;73:60-9. doi: 10.1016/j.nbd.2014.09.015. Epub 2014 Oct 2.

PMID:
25281318
20.

Chronic nandrolone decanoate exposure during adolescence affects emotional behavior and monoaminergic neurotransmission in adulthood.

Rainer Q, Speziali S, Rubino T, Dominguez-Lopez S, Bambico FR, Gobbi G, Parolaro D.

Neuropharmacology. 2014 Aug;83:79-88. doi: 10.1016/j.neuropharm.2014.03.015. Epub 2014 Apr 8.

PMID:
24721625
21.

Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect.

Solinas M, Massi P, Cinquina V, Valenti M, Bolognini D, Gariboldi M, Monti E, Rubino T, Parolaro D.

PLoS One. 2013 Oct 21;8(10):e76918. doi: 10.1371/journal.pone.0076918. eCollection 2013.

22.

Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats.

Zamberletti E, Beggiato S, Steardo L Jr, Prini P, Antonelli T, Ferraro L, Rubino T, Parolaro D.

Neurobiol Dis. 2014 Mar;63:35-47. doi: 10.1016/j.nbd.2013.10.028. Epub 2013 Nov 4.

PMID:
24200867
23.

Cannabis abuse in adolescence and the risk of psychosis: a brief review of the preclinical evidence.

Rubino T, Parolaro D.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:41-4. doi: 10.1016/j.pnpbp.2013.07.020. Epub 2013 Aug 1. Review.

PMID:
23916409
24.

Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure.

Llorente-Berzal A, Assis MA, Rubino T, Zamberletti E, Marco EM, Parolaro D, Ambrosio E, Viveros MP.

Pharmacol Res. 2013 Aug;74:23-33. doi: 10.1016/j.phrs.2013.05.001. Epub 2013 May 14.

PMID:
23680694
25.

Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-)) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect.

Sala M, Braida D, Donzelli A, Martucci R, Busnelli M, Bulgheroni E, Rubino T, Parolaro D, Nishimori K, Chini B.

J Neuroendocrinol. 2013 Feb;25(2):107-18. doi: 10.1111/j.1365-2826.2012.02385.x.

PMID:
22967062
26.

Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation.

Zamberletti E, Piscitelli F, Cadeddu F, Rubino T, Fratta W, Fadda P, Di Marzo V, Parolaro D.

Br J Pharmacol. 2012 Dec;167(8):1652-64. doi: 10.1111/j.1476-5381.2012.02095.x.

27.

The endocannabinoid system and schizophrenia: integration of evidence.

Zamberletti E, Rubino T, Parolaro D.

Curr Pharm Des. 2012;18(32):4980-90. Review.

PMID:
22716159
28.

Cannabidiol inhibits angiogenesis by multiple mechanisms.

Solinas M, Massi P, Cantelmo AR, Cattaneo MG, Cammarota R, Bartolini D, Cinquina V, Valenti M, Vicentini LM, Noonan DM, Albini A, Parolaro D.

Br J Pharmacol. 2012 Nov;167(6):1218-31. doi: 10.1111/j.1476-5381.2012.02050.x.

29.

Cannabidiol as potential anticancer drug.

Massi P, Solinas M, Cinquina V, Parolaro D.

Br J Clin Pharmacol. 2013 Feb;75(2):303-12. doi: 10.1111/j.1365-2125.2012.04298.x. Review.

30.

SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance.

Nazzaro C, Greco B, Cerovic M, Baxter P, Rubino T, Trusel M, Parolaro D, Tkatch T, Benfenati F, Pedarzani P, Tonini R.

Nat Neurosci. 2012 Jan 8;15(2):284-93. doi: 10.1038/nn.3022.

PMID:
22231426
31.

Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats.

Zamberletti E, Prini P, Speziali S, Gabaglio M, Solinas M, Parolaro D, Rubino T.

Neuroscience. 2012 Mar 1;204:245-57. doi: 10.1016/j.neuroscience.2011.11.038. Epub 2011 Nov 29.

PMID:
22178986
32.

Sexually dimorphic effects of cannabinoid compounds on emotion and cognition.

Rubino T, Parolaro D.

Front Behav Neurosci. 2011 Sep 28;5:64. doi: 10.3389/fnbeh.2011.00064. eCollection 2011.

33.

Adolescent exposure to cannabis as a risk factor for psychiatric disorders.

Rubino T, Zamberletti E, Parolaro D.

J Psychopharmacol. 2012 Jan;26(1):177-88. doi: 10.1177/0269881111405362. Epub 2011 Jul 18. Review.

PMID:
21768160
34.

AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor.

Bolognini D, Cascio MG, Parolaro D, Pertwee RG.

Br J Pharmacol. 2012 Apr;165(8):2561-74. doi: 10.1111/j.1476-5381.2011.01503.x.

35.

Binding of δ9-tetrahydrocannabinol and diazepam to human serum albumin.

Fanali G, Cao Y, Ascenzi P, Trezza V, Rubino T, Parolaro D, Fasano M.

IUBMB Life. 2011 Jun;63(6):446-51. doi: 10.1002/iub.466. Epub 2011 May 9.

36.

Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism.

Sala M, Braida D, Lentini D, Busnelli M, Bulgheroni E, Capurro V, Finardi A, Donzelli A, Pattini L, Rubino T, Parolaro D, Nishimori K, Parenti M, Chini B.

Biol Psychiatry. 2011 May 1;69(9):875-82. doi: 10.1016/j.biopsych.2010.12.022. Epub 2011 Feb 21.

PMID:
21306704
37.

Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251.

Zamberletti E, Viganò D, Guidali C, Rubino T, Parolaro D.

Int J Neuropsychopharmacol. 2012 Mar;15(2):267-80. doi: 10.1017/S1461145710001185. Epub 2010 Oct 6.

PMID:
20923599
38.

Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats.

Realini N, Vigano' D, Guidali C, Zamberletti E, Rubino T, Parolaro D.

Neuropharmacology. 2011 Feb-Mar;60(2-3):235-43. doi: 10.1016/j.neuropharm.2010.09.003. Epub 2010 Sep 17.

PMID:
20850463
39.
40.

The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice.

Bolognini D, Costa B, Maione S, Comelli F, Marini P, Di Marzo V, Parolaro D, Ross RA, Gauson LA, Cascio MG, Pertwee RG.

Br J Pharmacol. 2010 Jun;160(3):677-87. doi: 10.1111/j.1476-5381.2010.00756.x.

41.

The endocannabinoid system and psychiatric disorders.

Parolaro D, Realini N, Vigano D, Guidali C, Rubino T.

Exp Neurol. 2010 Jul;224(1):3-14. doi: 10.1016/j.expneurol.2010.03.018. Epub 2010 Mar 29. Review.

PMID:
20353783
42.

Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.

Guidali C, Viganò D, Petrosino S, Zamberletti E, Realini N, Binelli G, Rubino T, Di Marzo V, Parolaro D.

Int J Neuropsychopharmacol. 2011 Feb;14(1):17-28. doi: 10.1017/S1461145710000209. Epub 2010 Mar 3.

PMID:
20196921
43.

Molecular mechanisms involved in the antitumor activity of cannabinoids on gliomas: role for oxidative stress.

Massi P, Valenti M, Solinas M, Parolaro D.

Cancers (Basel). 2010 May 26;2(2):1013-26. doi: 10.3390/cancers2021013.

44.

Cellular mechanisms underlying the interaction between cannabinoid and opioid system.

Parolaro D, Rubino T, Viganò D, Massi P, Guidali C, Realini N.

Curr Drug Targets. 2010 Apr;11(4):393-405. Review.

PMID:
20017730
45.

Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.

Realini N, Rubino T, Parolaro D.

Pharmacol Res. 2009 Aug;60(2):132-8. doi: 10.1016/j.phrs.2009.03.006. Epub 2009 Mar 17. Review.

PMID:
19559364
46.

Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.

Braida D, Capurro V, Zani A, Rubino T, Viganò D, Parolaro D, Sala M.

Br J Pharmacol. 2009 Jul;157(5):844-53. doi: 10.1111/j.1476-5381.2009.00230.x. Epub 2009 May 5.

47.

The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex.

Rubino T, Realini N, Braida D, Alberio T, Capurro V, Viganò D, Guidali C, Sala M, Fasano M, Parolaro D.

Neurotox Res. 2009 May;15(4):291-302. doi: 10.1007/s12640-009-9031-3. Epub 2009 Feb 28.

PMID:
19384563
48.

Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat: Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring.

Cocchi D, Tulipano G, Colciago A, Sibilia V, Pagani F, Viganò D, Rubino T, Parolaro D, Bonfanti P, Colombo A, Celotti F.

Toxicol Appl Pharmacol. 2009 Jun 1;237(2):127-36. doi: 10.1016/j.taap.2009.03.008. Epub 2009 Mar 24.

PMID:
19327374
49.

Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood.

Rubino T, Realini N, Braida D, Guidi S, Capurro V, Viganò D, Guidali C, Pinter M, Sala M, Bartesaghi R, Parolaro D.

Hippocampus. 2009 Aug;19(8):763-72. doi: 10.1002/hipo.20554.

PMID:
19156848
50.

Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas.

Marco EM, Rubino T, Adriani W, Viveros MP, Parolaro D, Laviola G.

Brain Res. 2009 Feb 27;1257:25-31. doi: 10.1016/j.brainres.2008.12.037. Epub 2008 Dec 24.

PMID:
19133243

Supplemental Content

Loading ...
Support Center